JPS57112329A - Drug against arterioschlerosis comprising 2,3- dihydroxypropyl ester of n-(7-chloro-4-quinolyl) anthranillic acid - Google Patents
Drug against arterioschlerosis comprising 2,3- dihydroxypropyl ester of n-(7-chloro-4-quinolyl) anthranillic acidInfo
- Publication number
- JPS57112329A JPS57112329A JP18401181A JP18401181A JPS57112329A JP S57112329 A JPS57112329 A JP S57112329A JP 18401181 A JP18401181 A JP 18401181A JP 18401181 A JP18401181 A JP 18401181A JP S57112329 A JPS57112329 A JP S57112329A
- Authority
- JP
- Japan
- Prior art keywords
- day
- arterioschlerosis
- quinolyl
- chloro
- drug against
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Abstract
PURPOSE: The titled pharmaceutical preparation having lowering action on lipid in the blood and low side effect even by long-term medication, comprising 2,3- dihydroxypropyl ester of N-(7-chloro-4-quinolyl)anthranillic acid.
CONSTITUTION: 0.01W100wt%, preferably 1W80wt% compound shown by the formula as an active ingredient is blended with an excipient, bulking agent, binder, wetting agent, to give a drug against arterioschlerosis in the form of powder, granule, tablet, sugar-coated tablet, capsule, supository, suspension, etc. An oral dose is 1W200mg/kg/day, preferably 10W100mg/kg/day, and a parenteral dose is 0.05W5mg/kg/day, preferably 0.2W1mg/kg/day, medicated one W divided four times.
COPYRIGHT: (C)1982,JPO&Japio
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP18401181A JPS57112329A (en) | 1981-11-17 | 1981-11-17 | Drug against arterioschlerosis comprising 2,3- dihydroxypropyl ester of n-(7-chloro-4-quinolyl) anthranillic acid |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP18401181A JPS57112329A (en) | 1981-11-17 | 1981-11-17 | Drug against arterioschlerosis comprising 2,3- dihydroxypropyl ester of n-(7-chloro-4-quinolyl) anthranillic acid |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP1989280A Division JPS56115718A (en) | 1980-02-20 | 1980-02-20 | Physiologically active agent containing 2,3- dihydroxypropyl ester of n- 7-chloro-4-quinolyl anthranylic acid |
Publications (1)
Publication Number | Publication Date |
---|---|
JPS57112329A true JPS57112329A (en) | 1982-07-13 |
Family
ID=16145762
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP18401181A Pending JPS57112329A (en) | 1981-11-17 | 1981-11-17 | Drug against arterioschlerosis comprising 2,3- dihydroxypropyl ester of n-(7-chloro-4-quinolyl) anthranillic acid |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPS57112329A (en) |
-
1981
- 1981-11-17 JP JP18401181A patent/JPS57112329A/en active Pending
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL80149A (en) | Pharmaceutical compositions containing toluidide derivatives against graft-versus-host diseases and autoimmune diseases | |
KR20030072608A (en) | Medicinal preparation containing 5-methyl-1-phenyl-2-(1h)-pyridone as active ingredient | |
DK555389D0 (en) | PHARMACEUTICAL PREPARATION | |
RU93036959A (en) | FREE SOLUBLE MEDICATION WITH SLOW-UP ACTION OF BIOLOGICALLY ACTIVE SUBSTANCES, ASSIGNED FOR RECEPTION INSIDE, THE METHOD OF ITS MANUFACTURE | |
CA2038744A1 (en) | Pharmaceutical composition containing slightly water-soluble drug | |
SE7704764L (en) | PREPARATION OF ORAL CARRIER BASE AND ITS MANUFACTURED DOSAGE UNITS | |
JPS5350316A (en) | Drug composition for oral administration | |
JPS57112329A (en) | Drug against arterioschlerosis comprising 2,3- dihydroxypropyl ester of n-(7-chloro-4-quinolyl) anthranillic acid | |
JPS57112327A (en) | Antidiabetic agent comprising 2,3-dihydroxypropyl ester of n-(7-chloro-4-quinolyl)anthranillic acid | |
JPS57112328A (en) | Hypotensor comprising 2,3-dihydroxypropyl ester of n-(7- chloro-4-quinolyl)anthranillic acid | |
JPS55122715A (en) | Antidiabetic agent | |
JPS6452721A (en) | Diabetic remedy containing 7-thiapprostaglandin e1 as active ingredient | |
JPS57114512A (en) | Antidia beticagent comprising (3-dimethyl-carbamoxy- phenyl)trimethyl ammonium derivative | |
JPS56115715A (en) | Physiologically active agent containing (3- dimethylcarbam-oxyphenyl) trimethyl ammonium derivative | |
JPS5612318A (en) | Agent for suppressing oxidation of lipid | |
JPS5675428A (en) | Hypoglycemic agent containing procainamide hydrochloride | |
JPS54132239A (en) | Anti-tumor agent | |
EP0367509A3 (en) | Formulations | |
JPS55136219A (en) | Diazepam oily drug | |
JPS643123A (en) | Remedy for skin inflammation | |
IE37288B1 (en) | Pharmaceutical compositions for use in the treatment of certain respiratory diseases or conditions in prematurely born children | |
IE43848L (en) | Pharmaceutical compositions | |
JPS57114519A (en) | Antiarteriosclerotic agent | |
JPS5640607A (en) | Drug composition | |
JPS57128625A (en) | Carcinostatic |